For example, hepatocyte growth factor receptor (HGFR), encoded by MET gene, was negatively associated with BMD (beta = −0.04, p = 3.9 × 10−5), Cabozantinib may be repurposed to treat osteoporosis as an inhibitor of HGFR which was supported by real-world observation (Pan et al., 2020; Ratta et al., 2021). Here, MET is linked to osteoporosis.